- Data on File. Geistlich Pharma AG, Wolhusen, Switzerland. (Non-clinical)
Download our new eBook and learn how to 4C predictability
Download our new eBook and learn how to 4C predictability
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
Geistlich unveils vallos®, a full line of allograft granules and fibers. Discover vallos®